Related Experiment Video
Updated: Sep 17, 2025

In Vivo Quantification of Hip Arthrokinematics during Dynamic Weight-bearing Activities using Dual Fluoroscopy
Published on: July 2, 2021
Myocardial Infarction Within One Year of Total Hip Arthroplasty Increases Medical Complications in a Time-Dependent
Alejandro M Holle1, Sayi P Boddu1, Jens T Verhey2
1Mayo Clinic Alix School of Medicine, Scottsdale, Arizona.
Insights
A recent myocardial infarction (MI) within six months before total hip arthroplasty (THA) significantly increases the risk of postoperative complications, including heart failure and mortality. Specific MI types and treatments further elevate these risks.
Area of Science:
- Cardiology
- Orthopedic Surgery
- Health Services Research
Background:
- Myocardial infarction (MI) is a critical comorbidity impacting surgical outcomes.
- Understanding the perioperative risks associated with prior MI before total hip arthroplasty (THA) is essential for patient management.
Purpose of the Study:
- To investigate the influence of the timing, type, and treatment of myocardial infarction (MI) preceding total hip arthroplasty (THA) on postoperative cardiac and general medical complications.
Main Methods:
- A retrospective analysis of a national administrative claims database was performed.
- Patients undergoing primary THA were identified and matched with controls.
- MI patients were stratified by the timing of their MI before THA (0-6, 6-12, 12-18, 18-24 months).
Main Results:
- A history of MI significantly increased the risk of postoperative MI (OR: 4.06), heart failure (OR: 1.65), and 90-day mortality (OR: 2.22).
- The highest risk of postoperative MI was observed within 6 months of THA, especially for type 1 MI (OR: 8.07) and percutaneous coronary intervention (PCI)-treated MI (OR: 14.09).
- ST-segment elevation myocardial infarctions (STEMIs) were associated with increased 90-day mortality (OR: 2.69), and inferior infarcts were linked to higher risks of postoperative MI and mortality.
Conclusions:
- Myocardial infarction occurring within six months prior to THA, particularly type 1 MI, STEMI, PCI-treated MI, and inferior MI, poses the greatest risk for adverse postoperative outcomes.
- These findings highlight the importance of considering MI timing, type, and treatment when assessing surgical risk for THA patients.
Background:
The purpose of this study was to evaluate how the timing, type, and treatment of a myocardial infarction (MI) before total hip arthroplasty (THA) affect postoperative cardiac and general medical complications.
Methods:
A retrospective comparative study was conducted using a national administrative claims database. Patients undergoing primary THA with at least two years of active data were included. Patients who had an MI within two years before THA were identified and matched 1:4 with controls based on demographic variables and comorbidities. The MI patients were stratified by timing of their MI before THA: MI zero to six months, six to 12 months, 12 to 18 months, and 18 to 24 months before THA. Rates of postoperative cardiac and general medical complications were compared among groups. Subanalyses on MI type, treatment, and location were performed.
Results:
A history of MI was associated with an increased risk of postoperative MI (odds ratio [OR]: 4.06; 95% confidence interval [CI]: 3.03 to 5.43), heart failure (OR: 1.65, 95% CI: 1.32 to 2.07), and 90-day mortality (OR: 2.22, 95% CI: 1.25 to 3.96). Risk of MI was highest for those who had an MI within 6 months of THA, particularly for type 1 MI (OR: 8.07, 95% CI: 5.74 to 11.34) and percutaneous coronary intervention-treated MI (OR: 14.09, 95% CI: 6.34 to 31.33). ST-segment elevation myocardial infarctions (STEMIs) and non-ST-segment elevation MIs carried distinct risks, with STEMIs increasing 90-day mortality compared to controls (OR: 2.69, 95% CI: 1.18 to 6.10). Anterior infarcts were linked to increased risk of postoperative MI, while inferior infarcts were linked to both postoperative MI and 90-day mortality.
Conclusions:
Myocardial infarction within six months, particularly type 1 MI, STEMI, percutaneous coronary intervention-treated MI, and inferior MI, carries the highest risk of postoperative MI, heart failure, and mortality.
More Related Videos
09:51The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
Published on: September 7, 2022
07:45The Use of Mixed Reality in Custom-Made Revision Hip Arthroplasty: A First Case Report
Published on: August 4, 2022
Related Concept Videos
Myocarditis III: Medical Management
Rheumatic Heart Disease I: Introduction
Myocarditis I: Introduction
Cardiac Catheterization I: Pre-Procedure Overview
Peripheral Artery Disease V: Postoperative Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care